Page 43 - MemoriaES-Eng
P. 43
www.ciberes.org
Main results Publications:
in 2013
• AlMudéVer P, MilArA J, de diego A, SerrAno-MollAr A, XAuBet A, PéreZ-ViZcAino
F, cogolludo A, cortiJo J. Role of tetrahidrobiopterin in pulmonary vascular
remodelling associated with pulmonary fibrosis. Thorax. 2013;68(10):938-48.
• u Bd, d M, d V, l r, c e, A-H A, M J, P cc,
HAlAngAnglAtJoSAnoBdulAFeZArkeYiASecki
MolinA-MolinA M. Eur Respir J. 2013;42(1):198-210.
• gABASA M, roYo d, MolinA-MolinA M, rocA-Ferrer J, PuJolS l, PicAdo c, XAuBet A, PeredA
J. Lung myofibroblasts are characterized by down-regulated ciclooxygenase-2
and its main metabolite, prostaglandin-E2. PLoS One. 2013;8(6):e65445.
Clinical Guidelines (2013):
íá
• Gua Española para el diagnostico y tratamiento de FPI:
X A, A J, B e, F-F e, F t, M-M
AuBetncocHeAolloernándeZABrellASrAnQuetolinAolinA
M, Montero MA, SerrAno-MollAr A. Guidelines for the diagnosis and treatment
of idiopathic pulmonary fibrosis. Sociedad Española de Neumología y Cirugía
Torcica (SEPAR). Research Group on Diffuse Pulmonary Diseases. Arch
Bronconeumol. Agosto de 2013; 49(8):343-53.
Innovation:
• Solicitud de patente europea; EP14382007.
13
20
T
OR
P
RE
L
A
NU
N
A
S /
E
ER
B
CI
43
